newsfilter
← Latest News
Business Wire·

Humanigen Announces Participation and Presentation at Multiple Conferences in November

Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,' announced that management will present and participate at multiple investors c